Veradermics (NYSE:MANE – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Saturday.
A number of other analysts have also issued reports on MANE. Cantor Fitzgerald assumed coverage on shares of Veradermics in a research note on Monday, March 2nd. They set an “overweight” rating for the company. Leerink Partners boosted their target price on shares of Veradermics from $75.00 to $90.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Weiss Ratings assumed coverage on shares of Veradermics in a research note on Tuesday, May 26th. They set a “sell (d+)” rating for the company. Needham & Company LLC assumed coverage on shares of Veradermics in a research note on Tuesday. They set a “buy” rating and a $136.00 target price for the company. Finally, Zacks Research raised shares of Veradermics to a “hold” rating in a research note on Tuesday, March 3rd. Five research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Veradermics currently has an average rating of “Moderate Buy” and a consensus price target of $109.00.
Check Out Our Latest Analysis on Veradermics
Veradermics Stock Down 9.1%
Veradermics (NYSE:MANE – Get Free Report) last posted its quarterly earnings data on Tuesday, May 12th. The company reported ($1.32) EPS for the quarter, missing the consensus estimate of ($0.56) by ($0.76).
About Veradermics
MANE is a global manufacturer and supplier of flavors, fragrances and ingredients for the food, beverage, personal care, household and fine fragrance markets. Headquartered in France, the company develops and produces aromatic solutions that are used by consumer goods companies, food processors, perfumers and formulators seeking sensory impact, taste modulation and olfactory character for their products.
The company’s product portfolio includes savory and sweet flavor systems, beverage concentrates, natural extracts, essential oils, fragrance compounds, cosmetic ingredients and specialty functional solutions such as taste enhancers and odor masking agents.
Read More
- Five stocks we like better than Veradermics
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for Veradermics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradermics and related companies with MarketBeat.com's FREE daily email newsletter.
